What caused the pre-market jump in 0876.HK stock?

The pre-market gain for 0876.HK stock on 24 Mar 2026 was driven by unusually heavy volume and short-term technical buying. No material HKEX filing was noted at the time; liquidity and sector flows in Healthcare likely amplified the move.

What is Meyka AI's current rating for 0876.HK stock?

Meyka AI rates 0876.HK at **61.19/100**, Grade **B**, with a Hold suggestion. This considers benchmark and sector comparisons, financial growth, key metrics and analyst inputs. Grades are model outputs and not investment advice.

What price targets exist for 0876.HK stock?

Meyka AI's model projects monthly **HK$0.18**, quarterly **HK$0.25**, and yearly **HK$0.14** for 0876.HK stock. These imply short-term upside but are model-based projections and not guarantees.

Is 0876.HK stock a short-term trade or long-term buy?

Given the sharp pre-market move, 0876.HK stock is suited to short-term traders who accept volatility. Long-term investors should wait for improved profitability and faster receivables turnover before increasing exposure.

HK Stocks

Kaisa Health 0876.HK +26.21% pre-market HKSE 24 Mar 2026: heavy volume

ByDanny Kontos March 24, 2026March 24, 2026

Kaisa Health Group (0876.HK) surged 26.21% in Hong Kong pre-market trade on 24 Mar 2026, rising to HK$0.13 on unusually heavy volume of 84,262,128 shares. This jump makes 0876.HK stock one of the top gainers in the Healthcare sector on the HKSE at the open. The move followed an intraday range between HK$0.09 and HK$0.14 and leaves the name trading well above its 200-day average of HK$0.08. Investors should weigh the rally against weak recent profitability and stretched receivables when sizing positions.